This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Colorectal Cancer in Patients with Early ... New research indicates that colorectal cancer diagnosed at an ... (22 Mar 2019)
Improved the gut of IBS-patients with ... Transplantation of feces from a healthy person to a patient ... (22 Mar 2019)
A television in the bedroom? Having a television in the bedroom during the preschool years ... (21 Mar 2019)
Commonly used heart drug associated with ... A drug commonly used to treat high blood pressure and angina is ... (17 Mar 2019)
Anti-vaccination activists using new ... Anti-vaccination activists are capitalising on radical new ... (20 Mar 2019)

e-info Archive

Rate this item
(0 votes)
Relvar Ellipta SPC
Rate this item
(0 votes)
Muscoril 4mg hard capsules SmPC
Rate this item
(0 votes)
1981. Augmentin® – The first clavulanate-potentiated amoxicillin was launched for oral use2 LEADERS WALK IN FRONT 1. “The Wright Brothers - First Flight, 1903”, EyeWitness to History, www.eyewitnesstohistory.com (2003) accessed on 28 May 2014. 2. White AR et al. Augmentin™ (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent; Journal of Antimicrobial Chemotherapy 2004; 53:S1 i3-i20. Mini Abridged Prescribing Information: Please refer to full Summary of Product Characteristics (SPC) before prescribing. Trade Names: Augmentin ES 600 mg/42.9 mg/5 ml powder for oral suspension; Augmentin-Duo 400 mg/57 mg/ 5 ml Powder for Oral Suspension. Active Ingredients: Amoxicillin (as trihydrate) and potassium clavulanate. Pharmaceutical Form: Powder for oral suspension. Augmentin ES: Each 1 ml of oral suspension contains amoxicillin trihydrate equivalent to 120 mg amoxicillin and potassium clavulanate equivalent to 8.58 mg of clavulanic acid; Augmentin-Duo: Each 1 ml of reconstituted product contains amoxicillin trihydrate equivalent to 80 mg amoxicillin and potassium clavulanate equivalent to 11.4 mg of clavulanic acid. Indications: Augmentin ES/Augmentin Duo: For the treatment of acute otitis media and community acquired pneumonia infections caused or thought likely to be caused by penicillin-resistant Streptococcus pneumoniae. Refer to SPCs for…

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…